Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids

Free Radical Biology and Medicine

Volumn 48, Issue 2, 2010, Pages 230-239

  Khoo, Nicholas K H ^a   Rudolph, Volker ^a,b   Cole, Marsha P ^a   Golin Bisello, Franca ^a   Schopfer, Francisco J ^a   Woodcock, Steven R ^a   Batthyany, Carlos ^c   Freeman, Bruce A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c INSTITUT PASTEUR DE MONTEVIDEO   (Uruguay)

Author keywords

Electrophiles; Endothelial cells; eNOS; HO 1; Nitrated fatty acids; Nitroalkenes; NO

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; FATTY ACID DERIVATIVE; HEME OXYGENASE 1; MESSENGER RNA; NITRIC OXIDE; OLEIC ACID; SERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NITRATION; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, THORACIC; CATTLE; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HEME OXYGENASE-1; HUMANS; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; NITRO COMPOUNDS; OLEIC ACID; PROTEIN PROCESSING, POST-TRANSLATIONAL; VASCULAR DISEASES;

EID: 73049089496     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.10.046     Document Type: Article

References (79)

1. Schopfer F.J., Baker P.R., Giles G., Chumley P., Batthyany C., Crawford J., Patel R.P., Hogg N., Branchaud B.P., Lancaster Jr. J.R., and Freeman B.A. Fatty acid transduction of nitric oxide signaling. Nitrolinoleic acid is a hydrophobically stabilized nitric oxide donor. J. Biol. Chem. 280 (2005) 19289-19297
2. Baker L.M., Baker P.R., Golin-Bisello F., Schopfer F.J., Fink M., Woodcock S.R., Branchaud B.P., Radi R., and Freeman B.A. Nitro-fatty acid reaction with glutathione and cysteine. Kinetic analysis of thiol alkylation by a Michael addition reaction. J. Biol. Chem. 282 (2007) 31085-31093
3. Batthyany C., Schopfer F.J., Baker P.R., Duran R., Baker L.M., Huang Y., Cervenansky C., Branchaud B.P., and Freeman B.A. Reversible post-translational modification of proteins by nitrated fatty acids in vivo. J. Biol. Chem. 281 (2006) 20450-20463
4. Cui T., Schopfer F.J., Zhang J., Chen K., Ichikawa T., Baker P.R., Batthyany C., Chacko B.K., Feng X., Patel R.P., Agarwal A., Freeman B.A., and Chen Y.E. Nitrated fatty acids: endogenous anti-inflammatory signaling mediators. J. Biol. Chem. 281 (2006) 35686-35698
5. Baker P.R., Lin Y., Schopfer F.J., Woodcock S.R., Groeger A.L., Batthyany C., Sweeney S., Long M.H., Iles K.E., Baker L.M., Branchaud B.P., Chen Y.E., and Freeman B.A. Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 280 (2005) 42464-42475
6. Schopfer F.J., Lin Y., Baker P.R., Cui T., Garcia-Barrio M., Zhang J., Chen K., Chen Y.E., and Freeman B.A. Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. Proc. Natl. Acad. Sci. USA 102 (2005) 2340-2345
7. Freeman B.A., Baker P.R., Schopfer F.J., Woodcock S.R., Napolitano A., and d'Ischia M. Nitro-fatty acid formation and signaling. J. Biol. Chem. 283 (2008) 15515-15519
8. Trostchansky A., Souza J.M., Ferreira A., Ferrari M., Blanco F., Trujillo M., Castro D., Cerecetto H., Baker P.R., O'Donnell V.B., and Rubbo H. Synthesis, isomer characterization, and anti-inflammatory properties of nitroarachidonate. Biochemistry 46 (2007) 4645-4653
9. Nadtochiy S.M., Baker P.R., Freeman B.A., and Brookes P.S. Mitochondrial nitroalkene formation and mild uncoupling in ischaemic preconditioning: implications for cardioprotection. Cardiovasc. Res. 82 (2009) 333-340
10. Rudolph V., Rudolph T.K., Schopfer F.J., Bonacci G., Woodcock S.R., Cole M.P., Baker P.R., Ramani R., and Freeman B.A. Endogenous generation and protective effects of nitro-oleate in a murine model of focal cardiac ischemia and reperfusion. Cardiovasc. Res. 85 (2009) 155-166
11. Ignarro L.J. Haem-dependent activation of cytosolic guanylate cyclase by nitric oxide: a widespread signal transduction mechanism. Biochem. Soc. Trans. 20 (1992) 465-469
12. O'Donnell V.B., and Freeman B.A. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ. Res. 88 (2001) 12-21
13. Harrison D.G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100 (1997) 2153-2157
14. Vasquez-Vivar J., Kalyanaraman B., and Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic. Res. 37 (2003) 121-127
15. Napoli C., and Ignarro L.J. Nitric oxide releasing drugs. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 97-123
16. Martinez-Gonzalez J., and Badimon L. Influence of statin use on endothelial function: from bench to clinics. Curr. Pharm. Des. 13 (2007) 1771-1786
17. Cai H., McNally J.S., Weber M., and Harrison D.G. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J. Mol. Cell. Cardiol. 37 (2004) 121-125
18. Drummond G.R., Cai H., Davis M.E., Ramasamy S., and Harrison D.G. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 86 (2000) 347-354
19. Weber M., Hagedorn C.H., Harrison D.G., and Searles C.D. Laminar shear stress and 3′ polyadenylation of eNOS mRNA. Circ. Res. 96 (2005) 1161-1168
20. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 (1999) 601-605
21. Boo Y.C., Hwang J., Sykes M., Michell B.J., Kemp B.E., Lum H., and Jo H. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am. J. Physiol., Heart Circ. Physiol. 283 (2002) H1819-H1828
22. Boo Y.C., Sorescu G., Boyd N., Shiojima I., Walsh K., Du J., and Jo H. Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A. J. Biol. Chem. 277 (2002) 3388-3396
23. Durante W., Kroll M.H., Christodoulides N., Peyton K.J., and Schafer A.I. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80 (1997) 557-564
24. Motterlini R., Foresti R., Intaglietta M., and Winslow R.M. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol., Heart Circ. Physiol. 270 (1996) H107-H114
25. Ryter S.W., Alam J., and Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86 (2006) 583-650
26. Gamboa A., Shibao C., Diedrich A., Choi L., Pohar B., Jordan J., Paranjape S., Farley G., and Biaggioni I. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 49 (2007) 170-177
27. Johnson R.A., Lavesa M., Askari B., Abraham N.G., and Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25 (1995) 166-169
28. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 93 (1996) 13176-13181
29. Zhao C.X., Xu X., Cui Y., Wang P., Wei X., Yang S., Edin M.L., Zeldin D.C., and Wang D.W. Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. J. Pharmacol. Exp. Ther. 328 (2009) 610-620
30. Sacerdoti D., Escalante B., Abraham N.G., McGiff J.C., Levere R.D., and Schwartzman M.L. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science 243 (1989) 388-390
31. Escalante B., Sacerdoti D., Davidian M.M., Laniado-Schwartzman M., and McGiff J.C. Chronic treatment with tin normalizes blood pressure in spontaneously hypertensive rats. Hypertension 17 (1991) 776-779
32. Schopfer F.J., Batthyany C., Baker P.R., Bonacci G., Cole M.P., Rudolph V., Groeger A., Rudolph T.K., Nadtochiy S., Brookes P.S., and Freeman B.A. Detection and quantification of protein adduction by electrophilic fatty acids: mitochondrial generation of fatty acid nitroalkene derivatives. Free Radic. Biol. Med. 46 (2009) 1250-1259
33. Poss W.B., Huecksteadt T.P., Panus P.C., Freeman B.A., and Hoidal J.R. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am. J. Physiol. 270 (1996) L941-946
34. Rudolph V., Schopfer F.J., Khoo N.K., Rudolph T.K., Cole M.P., Woodcock S.R., Bonacci G., Groeger A.L., Golin-Bisello F., Chen C.S., Baker P.R., and Freeman B.A. Nitro-fatty acid metabolome: saturation, desaturation, beta-oxidation, and protein adduction. J. Biol. Chem. 284 (2009) 1461-1473
35. Cole M.P., Rudolph T.K., Khoo N.K.H., Motanya U.N., Golin-Bisllo F., Wertz J.W., Schopfer F.J., Woodcock S.R., Ali M.S., Rudolph V., Zhang J., Chen Y.E., Agarwal A., Freeman B.A., and Bauer P.M. Nitro-fatty acid inhibition of neointima formation after endoluminal vessel injury. Circ. Res. 105 (2009) 965-972
36. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
37. Anter E., Thomas S.R., Schulz E., Shapira O.M., Vita J.A., and Keaney Jr. J.F. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J. Biol. Chem. 279 (2004) 46637-46643
38. Chen Z., Yuhanna I.S., Galcheva-Gargova Z., Karas R.H., Mendelsohn M.E., and Shaul P.W. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103 (1999) 401-406
39. Ferreira A.M., Ferrari M., Trostchansky A., Batthyany C., Souza J.M., Alvarez M.N., Lopez G.V., Baker P.R., Schopfer F.J., O'Donnell V., Freeman B.A., and Rubbo H. Macrophage activation induces formation of the anti-inflammatory lipid cholesteryl-nitrolinoleate. Biochem. J. 417 (2008) 223-234
40. Lim D.G., Sweeney S., Bloodsworth A., White C.R., Chumley P.H., Krishna N.R., Schopfer F., O'Donnell V.B., Eiserich J.P., and Freeman B.A. Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc. Natl. Acad. Sci. USA 99 (2002) 15941-15946
41. Wright M.M., Schopfer F.J., Baker P.R., Vidyasagar V., Powell P., Chumley P., Iles K.E., Freeman B.A., and Agarwal A. Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression. Proc. Natl. Acad. Sci. USA 103 (2006) 4299-4304
42. Coles B., Bloodsworth A., Clark S.R., Lewis M.J., Cross A.R., Freeman B.A., and O'Donnell V.B. Nitrolinoleate inhibits superoxide generation, degranulation, and integrin expression by human neutrophils: novel antiinflammatory properties of nitric oxide-derived reactive species in vascular cells. Circ. Res. 91 (2002) 375-381
43. Coles B., Bloodsworth A., Eiserich J.P., Coffey M.J., McLoughlin R.M., Giddings J.C., Lewis M.J., Haslam R.J., Freeman B.A., and O'Donnell V.B. Nitrolinoleate inhibits platelet activation by attenuating calcium mobilization and inducing phosphorylation of vasodilator-stimulated phosphoprotein through elevation of cAMP. J. Biol. Chem. 277 (2002) 5832-5840
44. Lin D., Saleh S., and Liebler D.C. Reversibility of covalent electrophile-protein adducts and chemical toxicity. Chem. Res. Toxicol. 21 (2008) 2361-2369
45. Ceaser E.K., Moellering D.R., Shiva S., Ramachandran A., Landar A., Venkartraman A., Crawford J., Patel R., Dickinson D.A., Ulasova E., Ji S., and Darley-Usmar V.M. Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem. Soc. Trans. 32 (2004) 151-155
46. Ishii T., Tatsuda E., Kumazawa S., Nakayama T., and Uchida K. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry 42 (2003) 3474-3480
47. Villacorta L., Zhang J., Garcia-Barrio M.T., Chen X.L., Freeman B.A., Chen Y.E., and Cui T. Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway. Am. J. Physiol., Heart Circ. Physiol. 293 (2007) H770-H776
48. Talalay P., De Long M.J., and Prochaska H.J. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA 85 (1988) 8261-8265
49. Prestera T., and Talalay P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. USA 92 (1995) 8965-8969
50. Rachakonda G., Xiong Y., Sekhar K.R., Stamer S.L., Liebler D.C., and Freeman M.L. Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem. Res. Toxicol. 21 (2008) 705-710
51. Liu X.M., Peyton K.J., Mendelev N.N., Wang H., Tulis D.A., and Durante W. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Mol. Pharmacol. 75 (2009) 208-217
52. Ndisang J.F., Wu L., Zhao W., and Wang R. Induction of heme oxygenase-1 and stimulation of cGMP production by hemin in aortic tissues from hypertensive rats. Blood 101 (2003) 3893-3900
53. Wang R. Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. Can. J. Physiol. Pharmacol. 76 (1998) 1-15
54. Freitas A., Alves-Filho J.C., Secco D.D., Neto A.F., Ferreira S.H., Barja-Fidalgo C., and Cunha F.Q. Heme oxygenase/carbon monoxide;biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br. J. Pharmacol. 149 (2006) 345-354
55. Thomas S.R., Witting P.K., and Drummond G.R. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 10 (2008) 1713-1765
56. Wright M.M., Kim J., Hock T.D., Leitinger N., Freeman B.A., and Agarwal A. Human heme oxygenase-1 induction by nitro-linoleic acid is mediated by cyclic AMP, AP-1, and E-box response element interactions. Biochem. J. 422 (2009) 353-361
57. Anderson H.D., Rahmutula D., and Gardner D.G. Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J. Biol. Chem. 279 (2004) 963-969
58. Bulotta S., Barsacchi R., Rotiroti D., Borgese N., and Clementi E. Activation of the endothelial nitric-oxide synthase by tumor necrosis factor-alpha. A novel feedback mechanism regulating cell death. J. Biol. Chem. 276 (2001) 6529-6536
59. Li J.M., and Shah A.M. Mechanism of endothelial cell NADPH oxidase activation by angiotensin II. Role of the p47phox subunit. J. Biol. Chem. 278 (2003) 12094-12100
60. Ramasamy S., Drummond G.R., Ahn J., Storek M., Pohl J., Parthasarathy S., and Harrison D.G. Modulation of expression of endothelial nitric oxide synthase by nordihydroguaiaretic acid, a phenolic antioxidant in cultured endothelial cells. Mol. Pharmacol. 56 (1999) 116-123
61. Michel T. Targeting and translocation of endothelial nitric oxide synthase. Braz. J. Med. Biol. Res. 32 (1999) 1361-1366
62. Liu J., Garcia-Cardena G., and Sessa W.C. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry 34 (1995) 12333-12340
63. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y., Anderson R.G., and Michel T. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 271 (1996) 6518-6522
64. Dudzinski D.M., Igarashi J., Greif D., and Michel T. The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 235-276
65. Fulton D., Gratton J.P., and Sessa W.C. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?. J. Pharmacol. Exp. Ther. 299 (2001) 818-824
66. Davis M.E., Grumbach I.M., Fukai T., Cutchins A., and Harrison D.G. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kappaB binding. J. Biol. Chem. 279 (2004) 163-168
67. Harris M.B., Ju H., Venema V.J., Liang H., Zou R., Michell B.J., Chen Z.P., Kemp B.E., and Venema R.C. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 276 (2001) 16587-16591
68. Fleming I., Fisslthaler B., Dimmeler S., Kemp B.E., and Busse R. Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 88 (2001) E68-E75
69. Ishikawa K., Sugawara D., Wang X., Suzuki K., Itabe H., Maruyama Y., and Lusis A.J. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ. Res. 88 (2001) 506-512
70. Juan S.H., Lee T.S., Tseng K.W., Liou J.Y., Shyue S.K., Wu K.K., and Chau L.Y. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104 (2001) 1519-1525
71. Hayashi T., Sumi D., Juliet P.A.R., Matsui-Hirai H., Asai-Tanaka Y., Kano H., Fukatsu A., Tsunekawa T., Miyazaki A., Iguchi A., and Ignarro L.J. Gene transfer of endothelial NO synthase, but not eNOS, plus inducible NOS regressed atherosclerosis in rabbits. Cardiovasc. Res. 61 (2004) 339-351
72. Mozes G., Kullo I.J., Mohacsi T.G., Cable D.G., Spector D.J., Crotty T.B., Gloviczki P., Katusic Z.S., and O'Brien T. Ex vivo gene transfer of endothelial nitric oxide synthase to atherosclerotic rabbit aortic rings improves relaxations to acetylcholine. Atherosclerosis 141 (1998) 265-271
73. Duckers H.J., Boehm M., True A.L., Yet S.F., San H., Park J.L., Clinton Webb R., Lee M.E., Nabel G.J., and Nabel E.G. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7 (2001) 693-698
74. Tulis D.A., Durante W., Liu X., Evans A.J., Peyton K.J., and Schafer A.I. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104 (2001) 2710-2715
75. Kim H.P., Wang X., Nakao A., Kim S.I., Murase N., Choi M.E., Ryter S.W., and Choi A.M. Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide. Proc. Natl. Acad. Sci. USA 102 (2005) 11319-11324
76. Tulis D.A., Durante W., Peyton K.J., Evans A.J., and Schafer A.I. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 155 (2001) 113-122
77. Tulis D.A., Keswani A.N., Peyton K.J., Wang H., Schafer A.I., and Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cell. Mol. Biol. (Noisy-le-grand) 51 (2005) 441-446
78. Cooney R., Hynes S.O., Sharif F., Howard L., and O'Brien T. Effect of gene delivery of NOS isoforms on intimal hyperplasia and endothelial regeneration after balloon injury. Gene Ther. 14 (2006) 396-404
79. Sharif F., Hynes S.O., Cooney R., Howard L., McMahon J., Daly K., Crowley J., Barry F., and O'Brien T. Gene-eluting Stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosis. Mol. Ther. 16 (2008) 1674-1680